TB-500

A synthetic peptide fragment associated with thymosin beta-4, examined in laboratory tissue-repair research.

TB-500 is a synthetic peptide corresponding to an active region of thymosin beta-4, a naturally occurring actin-binding protein. In the published literature it appears predominantly in tissue-repair, cell-migration, and actin-regulation research models. Describing it as "studied in" these areas indicates where scientific attention has been directed, not a claim of any result. This page is background about the molecule as a research material and is not medical guidance or intended for human use.

Classification and structure

TB-500 is classified as a synthetic peptide fragment. It reproduces a short sequence derived from thymosin beta-4, a G-actin-sequestering protein widely present in mammalian cells. The fragment is of interest to researchers because thymosin beta-4 contains the actin-binding domain that has been the subject of cytoskeletal-dynamics research. As a laboratory material it is handled as a research compound rather than a formulated product.

Areas of research

TB-500 appears in several distinct areas of the scientific literature.

• Actin regulation — Investigated in research examining actin sequestration and cytoskeletal organization at the cellular level.
• Tissue-repair models — Appears in the literature on cell migration and wound-related research models.
• Angiogenesis research — Has been the subject of research examining endothelial cell behavior in vitro.

As always in this library, describing a compound as “studied in” an area is a statement about where scientific attention has gone — not a claim that it produces any result in humans or animals.

Handling and verification

Store lyophilized material cold and protected from light and moisture, following standard peptide-handling practice. Every in-stock lot ships with a verifiable third-party certificate of analysis (COA) documenting identity and purity.